Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice

Balaji Balasa, Caishu Deng, Jae Lee, Linda M. Bradley, Dyana K. Dalton, Premkumar Christadoss, Nora Sarvetnick

Research output: Contribution to journalArticle

159 Citations (Scopus)

Abstract

Experimental autoimmune myasthenia gravis (EAMG) is an animal model of human myasthenia gravis (MG). In mice, EAMG is induced by immunization with Torpedo californica acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA). However, the role of cytokines in the pathogenesis of EAMG is not clear. Because EAMG is an antibody-mediated disease, it is of the prevailing notion that Th2 but not Th1 cytokines play a role in the pathogenesis of this disease. To test the hypothesis that the Th1 cytokine, interferon (IFN)-γ plays a role in the development of EAMG, we immunized IFN-γ knockout (IFN-gko) (-/-) mice and wild-type (WT) (+/+) mice of H-2(b) haplotype with AChR in CFA. We observed that AChR-primed lymph node cells from IFN-gko mice proliferated normally to AChR and to its dominant pathogenic α146-162 sequence when compared with these cells from the WT mice. However, the IFN-gko mice had no signs of muscle weakness and remained resistant to clinical EAMG at a time when the WT mice exhibited severe muscle weakness and some died. The resistance of IFN-gko mice was associated with greatly reduced levels of circulating antiAChR antibody levels compared with those in the WT mice. Comparatively, immune sera from IFN-gko mice showed a dramatic reduction in mouse AChR-specific IgG1 and IgG2a antibodies. However, keyhole limpet hemocyanin (KLH)-priming of IFN-gko mice readily elicited both T cell and antibody responses, suggesting that IFN-γ regulates the humoral immune response distinctly to self (AChR) versus foreign (KLH) antigens. We conclude that IFN-γ is required for the generation of a pathogenic anti- AChR humoral immune response and for conferring susceptibility of mice to clinical EAMG.

Original languageEnglish (US)
Pages (from-to)385-391
Number of pages7
JournalJournal of Experimental Medicine
Volume186
Issue number3
DOIs
StatePublished - Aug 4 1997

Fingerprint

Autoimmune Experimental Myasthenia Gravis
Cholinergic Receptors
Interferons
Freund's Adjuvant
Muscle Weakness
Humoral Immunity
Cytokines
Antibodies
Torpedo
Myasthenia Gravis

ASJC Scopus subject areas

  • Immunology

Cite this

Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice. / Balasa, Balaji; Deng, Caishu; Lee, Jae; Bradley, Linda M.; Dalton, Dyana K.; Christadoss, Premkumar; Sarvetnick, Nora.

In: Journal of Experimental Medicine, Vol. 186, No. 3, 04.08.1997, p. 385-391.

Research output: Contribution to journalArticle

Balasa, Balaji ; Deng, Caishu ; Lee, Jae ; Bradley, Linda M. ; Dalton, Dyana K. ; Christadoss, Premkumar ; Sarvetnick, Nora. / Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice. In: Journal of Experimental Medicine. 1997 ; Vol. 186, No. 3. pp. 385-391.
@article{66b98c905fe9487e80b489c26742ba34,
title = "Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice",
abstract = "Experimental autoimmune myasthenia gravis (EAMG) is an animal model of human myasthenia gravis (MG). In mice, EAMG is induced by immunization with Torpedo californica acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA). However, the role of cytokines in the pathogenesis of EAMG is not clear. Because EAMG is an antibody-mediated disease, it is of the prevailing notion that Th2 but not Th1 cytokines play a role in the pathogenesis of this disease. To test the hypothesis that the Th1 cytokine, interferon (IFN)-γ plays a role in the development of EAMG, we immunized IFN-γ knockout (IFN-gko) (-/-) mice and wild-type (WT) (+/+) mice of H-2(b) haplotype with AChR in CFA. We observed that AChR-primed lymph node cells from IFN-gko mice proliferated normally to AChR and to its dominant pathogenic α146-162 sequence when compared with these cells from the WT mice. However, the IFN-gko mice had no signs of muscle weakness and remained resistant to clinical EAMG at a time when the WT mice exhibited severe muscle weakness and some died. The resistance of IFN-gko mice was associated with greatly reduced levels of circulating antiAChR antibody levels compared with those in the WT mice. Comparatively, immune sera from IFN-gko mice showed a dramatic reduction in mouse AChR-specific IgG1 and IgG2a antibodies. However, keyhole limpet hemocyanin (KLH)-priming of IFN-gko mice readily elicited both T cell and antibody responses, suggesting that IFN-γ regulates the humoral immune response distinctly to self (AChR) versus foreign (KLH) antigens. We conclude that IFN-γ is required for the generation of a pathogenic anti- AChR humoral immune response and for conferring susceptibility of mice to clinical EAMG.",
author = "Balaji Balasa and Caishu Deng and Jae Lee and Bradley, {Linda M.} and Dalton, {Dyana K.} and Premkumar Christadoss and Nora Sarvetnick",
year = "1997",
month = "8",
day = "4",
doi = "10.1084/jem.186.3.385",
language = "English (US)",
volume = "186",
pages = "385--391",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune Myasthenia gravis in mice

AU - Balasa, Balaji

AU - Deng, Caishu

AU - Lee, Jae

AU - Bradley, Linda M.

AU - Dalton, Dyana K.

AU - Christadoss, Premkumar

AU - Sarvetnick, Nora

PY - 1997/8/4

Y1 - 1997/8/4

N2 - Experimental autoimmune myasthenia gravis (EAMG) is an animal model of human myasthenia gravis (MG). In mice, EAMG is induced by immunization with Torpedo californica acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA). However, the role of cytokines in the pathogenesis of EAMG is not clear. Because EAMG is an antibody-mediated disease, it is of the prevailing notion that Th2 but not Th1 cytokines play a role in the pathogenesis of this disease. To test the hypothesis that the Th1 cytokine, interferon (IFN)-γ plays a role in the development of EAMG, we immunized IFN-γ knockout (IFN-gko) (-/-) mice and wild-type (WT) (+/+) mice of H-2(b) haplotype with AChR in CFA. We observed that AChR-primed lymph node cells from IFN-gko mice proliferated normally to AChR and to its dominant pathogenic α146-162 sequence when compared with these cells from the WT mice. However, the IFN-gko mice had no signs of muscle weakness and remained resistant to clinical EAMG at a time when the WT mice exhibited severe muscle weakness and some died. The resistance of IFN-gko mice was associated with greatly reduced levels of circulating antiAChR antibody levels compared with those in the WT mice. Comparatively, immune sera from IFN-gko mice showed a dramatic reduction in mouse AChR-specific IgG1 and IgG2a antibodies. However, keyhole limpet hemocyanin (KLH)-priming of IFN-gko mice readily elicited both T cell and antibody responses, suggesting that IFN-γ regulates the humoral immune response distinctly to self (AChR) versus foreign (KLH) antigens. We conclude that IFN-γ is required for the generation of a pathogenic anti- AChR humoral immune response and for conferring susceptibility of mice to clinical EAMG.

AB - Experimental autoimmune myasthenia gravis (EAMG) is an animal model of human myasthenia gravis (MG). In mice, EAMG is induced by immunization with Torpedo californica acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA). However, the role of cytokines in the pathogenesis of EAMG is not clear. Because EAMG is an antibody-mediated disease, it is of the prevailing notion that Th2 but not Th1 cytokines play a role in the pathogenesis of this disease. To test the hypothesis that the Th1 cytokine, interferon (IFN)-γ plays a role in the development of EAMG, we immunized IFN-γ knockout (IFN-gko) (-/-) mice and wild-type (WT) (+/+) mice of H-2(b) haplotype with AChR in CFA. We observed that AChR-primed lymph node cells from IFN-gko mice proliferated normally to AChR and to its dominant pathogenic α146-162 sequence when compared with these cells from the WT mice. However, the IFN-gko mice had no signs of muscle weakness and remained resistant to clinical EAMG at a time when the WT mice exhibited severe muscle weakness and some died. The resistance of IFN-gko mice was associated with greatly reduced levels of circulating antiAChR antibody levels compared with those in the WT mice. Comparatively, immune sera from IFN-gko mice showed a dramatic reduction in mouse AChR-specific IgG1 and IgG2a antibodies. However, keyhole limpet hemocyanin (KLH)-priming of IFN-gko mice readily elicited both T cell and antibody responses, suggesting that IFN-γ regulates the humoral immune response distinctly to self (AChR) versus foreign (KLH) antigens. We conclude that IFN-γ is required for the generation of a pathogenic anti- AChR humoral immune response and for conferring susceptibility of mice to clinical EAMG.

UR - http://www.scopus.com/inward/record.url?scp=0030878993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030878993&partnerID=8YFLogxK

U2 - 10.1084/jem.186.3.385

DO - 10.1084/jem.186.3.385

M3 - Article

VL - 186

SP - 385

EP - 391

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 3

ER -